St. Antonius Hospital

AMT Medical Secures $25M Series B to Transform Coronary Bypass Surgery with Minimally Invasive Technology

a month ago

• AMT Medical has raised $25 million in Series B funding to advance its ELANA® Heart Bypass System, a minimally invasive alternative to traditional open-heart bypass surgery. • The innovative technology uses a sutureless anastomosis technique with a proprietary clip and excimer laser, enabling beating-heart procedures that eliminate stroke risks and potentially reduce costs by over 50%. • With the new funding, AMT Medical aims to complete first-in-human trials in Europe, obtain CE marking by 2026, and initiate clinical trials in the United States for both open and robotic surgical settings.

Endovascular Therapy Significantly Improves Outcomes in Vertebrobasilar Stroke

5 months ago

• A meta-analysis shows endovascular therapy (EVT) significantly improves outcomes after vertebrobasilar stroke compared to standard medical management. • Patients undergoing EVT were 2.5 times more likely to regain independent walking ability three months post-stroke. • The VERITAS collaboration's findings are expected to influence global stroke treatment guidelines, enhancing patient recovery. • Vertebrobasilar strokes, though a small fraction of ischemic strokes, have high mortality rates, which EVT can significantly reduce.

Vaderis' VAD044 Shows Promise in Hereditary Hemorrhagic Telangiectasia Trial

9 months ago

• Vaderis Therapeutics' VAD044 demonstrated favorable safety and tolerability in a Phase 2 proof-of-concept trial for Hereditary Hemorrhagic Telangiectasia (HHT). • The trial showed clinically meaningful improvements in epistaxis frequency, duration, and epistaxis-free days in HHT patients treated with VAD044. • Interim data from an open-label extension study indicate continued improvements in bleeding parameters with sustained VAD044 treatment over six months. • Vaderis is engaging with health authorities to advance VAD044 into pivotal phase development for HHT, a disease with no approved treatments.